Abstract
Introduction
Skeletal metastases of advanced prostatic cancer are usually osteoblastic in appearance. Osteolytic secondaries are an uncommon entity. In such scenarios, it is important to differentiate prostatic metastases from other pathologies which give an identical radiological appearance, such as multiple myeloma. Another important point to remember is that neurological complications secondary to prostatic metastases are quite uncommon.
Case presentation
We describe a man with advanced prostatic carcinoma who presented to us with an uncommon combination of sudden onset complete paraplegia associated with diminished sensation in the lower half of the body and diffuse osteolytic lesions in the entire skeletal system. On detailed workup, it was found that his prostatic specific antigen (PSA) was grossly elevated. Markers for multiple myeloma were negative. Accordingly, computerized tomography of the abdomen was performed. The latter revealed an enlarged prostate gland infiltrating into the bladder base. Histopathological analysis from the prostate as well as the bone marrow showed an identical picture thereby confirming our diagnosis. The individual underwent palliative spinal canal decompression following which he was put on anti-androgenic treatment. At one year follow up, he was ambulatory and able to walk with use of crutches.
Discussion
To the best of our knowledge, this is the first reported case of osteolytic prostatic metastases presenting as complete paraplegia. In this situation, in addition to evaluation for prostate CA, we also recommend screening for multiple myeloma as the clinico-radiological profile of the two diseases are similar but their management is very different.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Segamwenge IL, Mgori NK, Yussuf SA, Mukulu CN, Nakangombe P, Ngalyuka PK, et al. Cancer of the prostate presenting with diffuse osteolytic metastatic bone lesions: a case report. J Med Case Rep. 2012;6:425.
Messiou C, Cook G, deSouza NM. Imaging metastatic bone disease from carcinoma of the prostate. Br J Cancer. 2009;101:1225–32.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer incidence and mortality worldwide: IARC CancerBase No.10. Int Agency Res Cancer. 2010. http://globocan.iarc.fr.
Langley RR, Fidler IJ. The seed and soil hypothesis revisited - the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer. 2011;128:2527–35.
Rajendiran G, Green L, Chhabra G. A rare presentation of prostate cancer with diffuse osteolytic metastases and PSA of 7242 ng/ml. Int J Case Rep Image. 2011;2:16–20.
Vinjamoori AH, Jagannathan JP, Shinagare AB, Taplin ME, Oh WK, Van den Abbeele AD, et al. Atypical metastases from prostate cancer: 10-year experience at a single institution. AJR Am J Roentgenol. 2012;199:367–72.
Idowu BM. Prostate carcinoma presenting with diffuse osteolytic metastases and supraclavicular lymphadenopathy mimicking multiple myeloma. Clin Case Rep. 2018;6:253–7.
Alabed YZ. Prostate cancer lytic bone metastases imaged with 18F-Fluorocholine PET/CT. Clin Nucl Med. 2018;43:220.
Sharma P, Karunanithi S, Dhull VS, Jain S, Bal C, Kumar R. Prostate cancer with lytic bone metastases: 18F-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and monitoring response to medical castration therapy. Indian J Nucl Med. 2013;28:178–9.
Bird VY, Domino PM, Sutkowski R, Stillings SA, Trejo-Lopez JA. Prostate cancer with metastatic lytic bone lesions: positive bone scan post docetaxel chemotherapy in the setting of clinically successful treatment. Urol Case Rep. 2016;6:12–4.
Migita T, Maeda K, Ogata N. A case of prostate cancer associated with osteolytic bone metastases. Hinyokika Kiyo (Acta Urologica Japanica). 1999;45:371–4. in Japanese.
Agheli A, Patsiornik Y, Chen Y, Chaudhry MR, Gerber H, Wang JC. Prostate carcinoma, presenting with a solitary osteolytic bone lesion to the right hip. Radio Case Rep. 2009;4:288.
Ansari MS, Nabi G, Aron M. Solitary radial head metastasis with wrist drop: a rare presentation of metastatic prostate cancer. Urol Int. 2003;70:77–9.
Bakhsh MU, Lee S, Ahmad S, Takher J, Pareek A, Syed U, et al. Should prostate cancer be considered as a differential diagnosis in patients with osteolytic bone lesions? Eur Rev Med Pharm Sci. 2015;19:4791–4.
Nanda S, Bhatt SP, Steinberg D, Volk SA. Unusual cause of generalized osteolytic vertebral lesions: a case report. J Med Case Rep. 2007;1:33.
Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine 2001;26:298–306.
Rabbani SA, Gladu J, Harakidas P, Jamison B, Goltzman D. Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo. Int J Cancer. 1999;80:257–64.
Benjamin R. Neurologic complications of prostate cancer. Am Fam Physician. 2002;65:1834–40.
Acknowledgements
The authors wish to acknowledge and thank the patient for allowing them to publish his clinical data.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gupta, A., Gahlot, N. & Elhence, P. Complete paraplegia with diffuse osteolytic skeletal metastases: an uncommon presentation of carcinoma of the prostate. Spinal Cord Ser Cases 6, 25 (2020). https://doi.org/10.1038/s41394-020-0276-7
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41394-020-0276-7
This article is cited by
-
MR imaging features to predict the type of bone metastasis in prostate cancer
Scientific Reports (2023)
